Patient-Reported Symptom Control of Diarrhea and Flushing in Patients with Neuroendocrine Tumors Treated with Lanreotide Depot/Autogel: Results from a Randomized, Placebo-Controlled, Double-Blind and 32-Week Open-Label Study.
about
Patient-Reported Symptom Control of Diarrhea and Flushing in Patients with Neuroendocrine Tumors Treated with Lanreotide Depot/Autogel: Results from a Randomized, Placebo-Controlled, Double-Blind and 32-Week Open-Label Study.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Patient-Reported Symptom Contr ...... and 32-Week Open-Label Study.
@en
Patient-Reported Symptom Contr ...... and 32-Week Open-Label Study.
@nl
type
label
Patient-Reported Symptom Contr ...... and 32-Week Open-Label Study.
@en
Patient-Reported Symptom Contr ...... and 32-Week Open-Label Study.
@nl
prefLabel
Patient-Reported Symptom Contr ...... and 32-Week Open-Label Study.
@en
Patient-Reported Symptom Contr ...... and 32-Week Open-Label Study.
@nl
P2093
P2860
P1433
P1476
Patient-Reported Symptom Contr ...... and 32-Week Open-Label Study.
@en
P2093
Aaron Vinik
Beloo Mirakhur
ELECT Study Group
Edward M Wolin
George A Fisher
Montaser Shaheen
Nilani Liyanage
Rodney F Pommier
Susan Pitman Lowenthal
P2860
P356
10.1634/THEONCOLOGIST.2017-0284
P577
2017-10-16T00:00:00Z